Targeting of a developmentally regulated epitope of CD43 for the treatment of acute leukemia-Reference-Cited by-同舟云学术

Targeting of a developmentally regulated epitope of CD43 for the treatment of acute leukemia

Published:2011-06-28 Issue:12 Volume:60 Page:1697-1706
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Jeon Yoon Kyung,Min Hye Sook,Lee Yoo Jeong,Kang Byung Hyun,Kim Eun Ji,Park Hyo Jin,Bae Youngmee,Lee Hyun Gyu,Park Weon Seo,Song Hyung Geun,Jung Kyeong Cheon,Park Seong Hoe

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-011-1066-7.pdf

Reference40 articles.

1. Adams GP, Weiner LM (2005) Monoclonal antibody therapy of cancer. Nat Biotechnol 23(9):1147–1157. doi: 10.1038/nbt1137

2. Gasparini G, Longo R, Torino F, Gattuso D, Morabito A, Toffoli G (2006) Is tailored therapy feasible in oncology? Crit Rev Oncol Hematol 57(1):79–101. doi: 10.1016/j.critrevonc.2005.07.003

3. Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC (2005) Monoclonal antibody successes in the clinic. Nat Biotechnol 23(9):1073–1078. doi: 10.1038/nbt0905-1073

4. Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, Watier H (2002) Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 99(3):754–758

5. Weng WK, Levy R (2003) Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol 21(21):3940–3947. doi: 10.1200/JCO.2003.05.013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax;Clinical Epigenetics;2024-03-26

2. Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia;Science Advances;2021-03-12

3. Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia;Journal for ImmunoTherapy of Cancer;2021-02

4. The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in De Novo Pediatric Acute Leukemias;Annals of Laboratory Medicine;2019-07-01

5. Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis;PLOS ONE;2016-03-24